Trial · NCT01105702
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Median Progression-Free Survival (PFS) | TBL/RT | 9.4 | 95% Confidence Interval 6.1 to 12.4 | months | |
| Median Overall Survival (OS) | TBL/RT | 18.5 | 95% Confidence Interval 14.7 to 20.8 | months | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 3 | Dermatitis | 1 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 4 | Dermatitis | 0 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 3 | DVT | 1 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 4 | DVT | 0 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 3 | Neurologic | 3 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 4 | Neurologic | 0 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 3 | Pneumonia | 1 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 4 | Pneumonia | 0 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 3 | Rash | 1 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 4 | Rash | 0 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 3 | Cough | 1 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 4 | Cough | 0 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 3 | Hyponatremia | 1 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 4 | Hyponatremia | 0 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 3 | Gastrointestinal | 2 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 4 | Gastrointestinal | 0 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 3 | Febril Neutropenia | 0 | participants | |
| Number of Patients With Grade 3 or 4 Adverse Events | Grade 4 | Febril Neutropenia | 1 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01105702/results